Methods of administering nalbuphine
US12274696B2 · kind B2 · utility
0Cited by
35References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2022 |
| Grant date | Apr 15, 2025 |
| Priority date | — |
| Expiry date | May 9, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods of treating nalbuphine-treatable disorders in a hepatically impaired patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.